Day: April 14, 2021

Microsoft doubles healthcare market with acquisition of Nuance

(Photo by Cavan ImagesGetty Images)

Microsoft is acquiring Nuance Communications in an all-cash transaction valued at $19.7 billion, inclusive of Nuance’s net debt. The transaction is intended to close this year.

Nuance is a cloud and software provider of conversational AI and cloud-based ambient clinical intelligence for healthcare systems.

Nuance’s products include the Dragon Ambient eXperience, Dragon Medical One and PowerScribe One for radiology reporting, all leading clinical speech recognition SaaS offerings built on Microsoft Azure. Nuance’s solutions work with electronic health records on clinical documentation. 

Mark Benjamin will remain CEO of Nuance, reporting to Scott Guthrie, executive vice president of Cloud & AI at Microsoft. 


With this acquisition, Microsoft is doubling its total addressable market in the healthcare provider space to nearly $500 billion. 

Nuance solutions are currently used by more than 55% of physicians and 75% of radiologists in the U.S., and used in 77%

Read More

CDC and FDA pause Johnson & Johnson vaccine over rare blood clot concerns

(Image by Luis Alvarez/Getty Photographs)

The Facilities for Illness Command and Prevention and the Food items and Drug Administration on Tuesday declared they are pausing the Johnson & Johnson vaccine due to considerations of many rare blood clotting conditions in people today who have received the vaccine.

The CDC and the Food and drug administration are reviewing data involving six noted U.S. conditions of a rare and significant form of blood clot in people today. This is out of far more than six.8 million doses of the Johnson & Johnson Janssen vaccine that have been administered in the United States as of Monday.

All six conditions transpired between girls between the ages of eighteen and 48, and symptoms transpired six to thirteen days following vaccination. 

Suitable now, these adverse events appear to be really rare, in accordance to Dr. Anne Schuchat, principal deputy director of the CDC and Dr. Peter

Read More